R&D Sponsored Advancing RSV and hMPV research through human challenge tria... Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.
Events Partner Content Welcome to the 2nd Chronic HBV Drug Development Summit Advance Combination Therapies, Outline Clinical Endpoints & Understand the Immunology Perspective to Achieve Functional Cures for Chronic Hepatitis B.
Events Partner Content 2nd Gene Therapy Immunogenicity Modulate, Measure & Predict Immune Response to GTx
Events Partner Content The 4th Annual Oncolytic Virotherapy Summit - Boston 2018 Join the 4th Oncolytic Virotherapy Summit in Boston
News Immunocore's T-cell therapy could provide HIV cure Treatment promises cure by reactivating immune cells to kill latent HIV-infected cells.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.